Polaris, Ludwig Institute initiate enrollment for ADI-PEG 20 phase 2 trial
ADI is a microbial enzyme, arginine deiminase that degrades the amino acid arginine. ADI-PEG 20 is ADI conjugated with polyethylene glycol (PEG), and can selectively kill cancer cells
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.